ESR1 and breast carcinoma: Further, the finding that this association is absent from ER+ tumors, suggests a possible intervention mechanism and calls for further study of a possibility of realigning regulation in breast cancer, from the harder-to-treat ER- phenotype, to the improved prognosis of ER+ phenotype.